Bi
BioNova
Shanghai CNFounded 201940 employees
Private CapbiotechPrivateCNS
Platform: BN-101 CNS
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BIO-708 | BIO-708 | Phase 2/3 | 1 | Menin | DLBCLMCC | ||
| Zenoosocimab | BIO-9307 | Phase 1 | 1 | TNFα | RABreast Ca | ||
| BIO-7835 | BIO-7835 | Phase 1/2 | 1 | USP1 | OCDIgAN |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)